10 Big Names Leading Wall Street Gains

Ten stocks soared higher on Wednesday, mirroring a broader market rally, as investors continued to take path from a flurry of strong corporate earnings and higher growth outlooks for the full year. Of the 10 firms, three climbed to new all-time highs.

Meanwhile, all Wall Street major indices finished in the green, led by the Nasdaq with a 0.65 percent gain, followed by the Dow Jones, up 0.48 percent, and the S&P 500 with 0.37 percent.

In this article, we spotlight the 10 companies that led Wednesday’s charge and detail the reasons behind their gains.

To come up with the list, we considered only the stocks with a $2 billion market capitalization and more than 5 million shares in trading volume.

Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexels

10. Sarepta Therapeutics Inc. (NASDAQ:SRPT)

Sarepta saw its share price jump by 15.25 percent on Wednesday to close at $18.67 apiece as investors took heart from an investment company’s bullish rating for its stock.

In a market note, Mizuho Securities raised its rating for Sarepta Therapeutics Inc. (NASDAQ:SRPT) to “outperform” from “neutral” while raising its price target by 36.8 percent to $26 from $19 previously. The new figure marked a 39 percent upside potential from its latest closing price.

Mizuho said the upgrade was based on its confidence in the Elevidys drug—a prescription therapy to treat over four-year-old patients with Duchenne muscular dystrophy—having raked in $131.5 million in sales in just the third quarter, and well ahead of its $50 million target, despite reports of deaths linked to the drug.

Meanwhile, Sarepta Therapeutics Inc. (NASDAQ:SRPT) swung to a net loss of $180 million in the period July to September, reversing a $33.6 million net income in the same period last year.

Revenues dropped by 14.5 percent to $399 million from $467 million year-on-year, amid lower revenues from Elevidys as a result of the shipping suspension in June 2025 due to the death reports.

9. Unity Software Inc. (NYSE:U)

Unity Software grew its share price by 18.09 percent on Wednesday to end at $42.36 apiece after beating earnings expectations for the third quarter of the year.

In an updated report, Unity Software Inc. (NYSE:U) said it was able to grow its revenues by 5.4 percent to $471 million from $447 million in the same period last year, beating its earlier guidance of $440 million to $450 million.

Revenues were primarily driven by higher subscription revenues and strong performance from the Unity Ad Network powered by Unity Vector.

However, Unity Software Inc. (NYSE:U) remained at a 1.6 percent higher net loss at $127 million versus $125 million year-on-year.

“Third-quarter results once again meaningfully exceeded expectations on both revenue and Adjusted EBITDA, powered by Unity Vector AI, as well as continued strength in Create. As consumer enthusiasm for interactive entertainment continues to grow, Unity is poised to grow with it,” the company said.

Looking ahead, Unity Software Inc. (NYSE:U) is targeting to hit revenues between $480 million and $490 million and adjusted EBITDA ranging from $110 million to $115 million.

8. DigitalOcean Holdings, Inc. (NYSE:DOCN)

DigitalOcean surged by 18.01 percent on Wednesday to close at $45.81 apiece as investors took heart from a stellar earnings performance in the third quarter and a higher growth outlook for full-year 2025.

In its updated earnings report, DigitalOcean Holdings, Inc. (NYSE:DOCN) said net income attributable to shareholders expanded by 380 percent to $158 million from $32.9 million in the same period last year on the back of strong momentum from its unified agentic cloud business.

Revenues increased by 15.7 percent to $229.6 million from $198.5 million year-on-year, while annual run-rate revenue increased by 16 percent to $919 million.

Encouraged by the results, DigitalOcean Holdings, Inc. (NYSE:DOCN) raised its outlook across most key growth metrics for the full-year 2025.

Total revenues are now targeted to grow between $896 million and $897 million, versus its previous outlook of $888 million to $892 million.

Adjusted EBITDA margin is expected to jump by 40.7 percent to 41 percent, higher than the previous target of 39 to 40 percent.

However, outlook for diluted net income per share was lowered to a range of $2 to $2.05 from $2.05 to $2.10 prior.

7. Zeta Global Holdings Corp. (NYSE:ZETA)

Zeta Global ended two straight days of losses on Wednesday, jumping 19.40 percent to close at $19.94 apiece as investors gobbled up shares following a stellar earnings performance and an upbeat outlook for full-year 2025.

In an updated report, Zeta Global Holdings Corp. (NYSE:ZETA) said it narrowed its net loss in the third quarter of the year by 79 percent to $3.6 million from $17.37 million in the same period last year.

Revenues also increased by 25.7 percent to $337.17 million from $268.29 million year-on-year, exceeding its previous guidance of $327 million to $329 million.

Zeta Global Holdings Corp. (NYSE:ZETA) Chairman and CEO David Steinberg attributed the growth to its artificial intelligence and data products, which he said were “superior” to its competitors.

“Our latest launch of Athena by Zeta, our AI conversational, superintelligent agent, combined with the momentum coming out of our most successful Zeta Live, and the continued success with One Zeta, reinforces our conviction in Zeta’s leadership and future in the martech landscape,” he said.

For full-year 2025, Zeta Global Holdings Corp. (NYSE:ZETA) raised its revenue guidance to a range of $1.273 billion to $1.276 billion, versus its previous outlook of $1.258 billion to $1.268 billion.

Adjusted EBITDA is now expected at $273.2 million to $274.1 million, as compared with $263.6 million to $265.6 million prior.

Zeta Global Holdings Corp. (NYSE:ZETA) also provided initial guidance for full-year 2026, with revenues targeted at $1.54 billion, or a nearly 21 percent growth from its updated 2025 outlook.

6. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)

Teva rallied to a new all-time high on Wednesday after a stellar performance in the third quarter solidified expectations for a profitable full-year 2025.

In intra-day trading, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) jumped to a new record high of $25 before trimming gains to finish the day just up by 20.23 percent at $24.60 apiece.

This followed the company’s net income of $460 million in the third quarter of the year, marking a 211 percent improvement from the $390 million net loss in the same period last year.

Revenues grew by 3.4 percent to $4.48 billion from $4.33 billion year-on-year, on the back of strong growth across its brands Austedo, Ajovy, and Uzedy, with sales jumping by 38 percent, 19 percent, and 24 percent, respectively.

Despite the results, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reduced the upper range of its revenue growth outlook to $17 billion from $17.2 billion previously, while the lower end was maintained at $16.8 billion.

For adjusted EBITDA, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) expects figures to end between $4.8 billion to $5 billion, higher than the previous lower end of $4.7 billion.

5. Rivian Automotive, Inc. (NASDAQ:RIVN)

Rivian recovered by 23.36 percent on Wednesday to close at $15.42 apiece as investors cheered its revenue expansion in the third quarter of the year.

In its financial statement, Rivian Automotive, Inc. (NASDAQ:RIVN) said revenues for the period jumped by 78 percent to $1.558 billion from $874 million in the same period last year on the back of higher revenues from automotive which grew 47 percent to $1.14 billion versus $776 million year-on-year.

Rivian Automotive, Inc. (NASDAQ:RIVN) said it achieved higher deliveries during the quarter as a result of higher selling prices and accelerated purchases ahead of the expiration of 45W tax credits.

“As we’ve said previously, we expect the third quarter will be our highest delivery quarter for the year,” Rivian Automotive, Inc. (NASDAQ:RIVN) said.

Meanwhile, revenues from software and service rose by 324 percent to $416 million from $98 million due to vehicle electrical architecture and software development carryovers from the previous quarter, remarketing, vehicle repair, and maintenance service.

However, net loss attributable to shareholders increased by 6.6 percent to $1.173 billion from $1.1 billion year-on-year.

For the full-year 2025, Rivian Automotive, Inc. (NASDAQ:RIVN) is maintaining its outlook for adjusted EBITDA loss of $2 billion to $2.25 billion, as well as capital expenditures of $1.8 billion to $1.9 billion.

It also targets to deliver between 41,500 and 43,500 vehicles for the full year.

4. Lumentum Holdings Inc. (NASDAQ:LITE)

Lumentum Holdings soared to a new 52-week high on Wednesday, as investors took path from a bullish analyst coverage and an improved earnings performance in the first quarter of fiscal year 2026.

At intra-day trading, the stock jumped to its highest price of $240.71 before paring gains to end the day just up by 23.57 percent at $232.75 apiece.

In a market note, investment firm Wolfe Research raised its price target for Lumentum Holdings Inc. (NASDAQ:LITE) to $240 from $150, while maintaining an “outperform” rating, on expectations that its indium phosphide laser solutions would highly benefit from the rapid development of the artificial intelligence industry.

Meanwhile, Lumentum Holdings Inc. (NASDAQ:LITE) announced that it swung to a net income of $4.2 million in the first quarter of fiscal year 2026 from a $82.4 million net loss in the same period last year. Net revenues jumped by 58.4 percent to $533.8 million from $336.9 million year-on-year.

“Our first-quarter results and forward guidance underscore our strong momentum across data center, data center interconnect, and long-haul markets,” said Lumentum Holdings Inc. (NASDAQ:LITE) President and CEO Michael Hurlston.

“Our guidance indicates we expect more than 20 percent sequential revenue growth, even before meaningful contributions from two of our next major growth engines—optical circuit switches and co-packaged optics. Our third driver, cloud transceivers, is expected to grow in our second quarter and should now be on a sustainable upward path. With our broad optical portfolio, we are well positioned to support the rapid expansion of AI compute,” he added.

3. SolarEdge Technologies, Inc. (NASDAQ:SEDG)

SolarEdge bounced back from a two-day loss on Wednesday to nearly hit its 52-week high, as investors cheered a strong earnings performance and a new partnership that would see the development of new technologies for next-generation AI data centers.

At the end of the trading session, SolarEdge Technologies, Inc. (NASDAQ:SEDG) surged by 28.91 percent to $41.02, or just 90 cents shy of its 52-week high of $41.92, after reporting a 96 percent lower net loss in the third quarter of the year at $50 million versus $1.23 billion in the same period last year.

Revenues also grew by 45 percent to $340 million from $235 million year-on-year.

“We’re making steady progress in our turnaround, with three consecutive quarters of revenue growth and improving margins, and we’re not done yet,” said SolarEdge Technologies, Inc. (NASDAQ:SEDG) CEO Shuki Nir.

“With energy taking an increasingly vital role in powering the global economy, we believe that SolarEdge is positioned for continued growth, sustained profitability, and leadership in smart energy solutions,” he added.

In other developments, SolarEdge Technologies, Inc. (NASDAQ:SEDG) said that it joined forces with Infineon Technologies AG for the design, optimization, and validation of a Solid-State Transformer (SST) platform for AI and hyperscale data centers.

According to the company, the SST is well positioned to play a crucial role in future, highly efficient 800-volt direct current (VDC) AI data center power architectures.

“It is essential that the data center industry is equipped with solutions that deliver higher levels of efficiency and reliability. SolarEdge’s deep expertise in DC architecture uniquely positions us to lead this transformation,” Nir added.

2. Teradata Corp. (NYSE:TDC)

Teradata saw its share prices climb by 32.59 percent to close at $27.46 apiece as investor sentiment was boosted by its strong earnings performance and a higher earnings outlook for full-year 2025.

In an updated report, Teradata Corp. (NYSE:TDC) said that net income jumped by 25 percent to $40 million from 32 million in the same period last year, despite revenues dropping by 5 percent to $416 million from $440 million year-on-year.

Notably, the revenue drop was lower than the company’s expected 7 to 9 percent decline.

“Q3 marked another quarter of solid execution as we beat our revenue and recurring revenue guidance ranges, as well as delivered non-GAAP earnings per share and free cash flow ahead of expectations,” said Teradata Corp. (NYSE:TDC) President and CEO Steve McMillan.

Following the results, the company raised its diluted earnings per share (EPS) growth outlook for full-year 2025 to a range of $1.22 to $1.26 from the $1.04 to $1.12 previously.

However, it maintained expectations of a revenue decline between 5 and 7 percent year-on-year, alongside a 3 to 5 percent recurring revenue drop in the same comparable period.

1. Lemonade Inc. (NYSE:LMND)

Lemonade rallied to a new all-time high on Wednesday after posting a strong earnings performance and raising its growth outlook for the full-year 2025.

At intra-day trading, Lemonade Inc. (NYSE:LMND) soared to its highest 52-week price of $79.71 before paring gains to end the day just up by 34.21 percent at $78.73 apiece.

Optimism was fueled by its third quarter earnings performance, having trimmed its net loss by 44.6 percent to $37.5 million from $67.7 million in the same period last year.

Revenues grew by 42 percent to $194.5 million from $136.6 million year-on-year, on the back of strong in-force premiums.

Following the results, Lemonade Inc. (NYSE:LMND) raised its full-year revenue guidance to a range of $727 million to $732 million from its previous outlook of $710 million to $715 million.

Adjusted EBITDA loss was also lowered to $127 million to $130 million from $135 million to $140 million prior.

For the fourth quarter alone, Lemonade Inc. (NYSE:LMND) expects revenues to hit $217 million to $222 million, while adjusted EBITDA loss is targeted at $13 million to $16 million.

While we acknowledge the potential of LMND to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LMND and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.